Specifically, we evaluated the EBV antigen-specific CD8 T cell clonotype composition and persistence in melanoma patients who were treated with non-myeloablative chemotherapy regimen, followed by adoptive cell transfer (ACT) of autologous peripheral blood mononuclear cells (PBMCs) [24,25]. This evidence concerns the gene CD8A and melanoma.